Skip to main content

Philip Santangelo wants to build a toolbox of mRNA drugs to activate or shut off specific genes to help the immune system fight cancer and other disorders.

New screening technique could accelerate and improve delivery of mRNA therapies

‘Species agnostic’ screening is the latest result of a powerful partnership between James Dahlman and Phil Santangelo